Therapix- Developing cannabinoid based pharmaceuticals
Therapix Biosciences (TASE: THXBY; OTCQB: THXBY), a biopharmaceutical Israeli-based company, owns, licenses and develops its Intellectual Property (IP) portfolio of prescribed cannabinoid drugs and novel delivery systems
Aim to reduce risk by allocating investments among various assets and technologies, and to maximize return by investing in different areas.
A point of access to promising Israeli ventures, leverage the local entrepreneurial ecosystem and connect it with international strategic partners.
Leverage the Publicly-traded entity in raising capital & awareness, to be a patient & transparent partner, and nurture our portfolio partnering, M&A or IPO.